Initial, long-term, and durable responses to terazosin, placebo, or other therapies for chronic prostatitis/chronic pelvic pain syndrome

Urology. 2005 Jul;66(1):231-2; author reply 232-3. doi: 10.1016/j.urology.2005.02.013.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Chronic Disease
  • Humans
  • Male
  • Pelvic Pain / drug therapy*
  • Prazosin / analogs & derivatives*
  • Prazosin / therapeutic use
  • Prostatitis / drug therapy*
  • Syndrome
  • Time Factors

Substances

  • Terazosin
  • Prazosin